Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

Promega Building Research Development Complex in Fitchburg, Wisconsin

01/17/2019
Promega, a global life science company, will construct a new research and development facility at the company’s campus in Fitchburg, Wisconsin. The company will invest $190 million and is expected to create 100 jobs.

The project, which is expected to be completed next year, will include a 270,000-square-foot R&D facility that will provide the proper infrastructure for Promega to respond to emerging opportunities in the global biotechnology and life science markets. Currently, R&D operations are spread across three buildings at the Fitchburg campus. This new three-story building will allow the company to consolidate these employees into a single facility.

"Promega’s investment solidifies the company’s continued commitment to Wisconsin and is a testament to the strength of our life science industry,” said Mark R. Hogan, Secretary & CEO of WEDC. “In addition to the jobs created by this project, this expansion will enable Promega to usher in a new era of innovation and research to develop new products and will position the company for future growth.”

In addition to the 100 jobs expected to be created by the expansion, a WEDC economic modeling study estimates the project could indirectly generate 260 additional jobs in the region. Those 360 new jobs could generate up to $4 million in state income tax revenue over a five-year period.

Wisconsin Economic Development Corporation awarded the company up to $1.5 million in tax credits over three years. Last year WEDC awarded Promega with up to $185,000 to support the company in moving some of its manufacturing facilities from California to Wisconsin. That project is expected to create 25 new jobs and make a capital investment of $750,000.

The amount of tax credits awarded to the company by WEDC are contingent upon the amount of capital investment the company makes in the project over three years. As is the case for all WEDC tax credit awards, the company must first make the capital investment before receiving any tax credits.

The Fitchburg facility manufactures enzymes and enzyme systems for the amplification and cloning of DNA, detection of gene expression, cell health or biochemical assays and protein analysis. As the corporate headquarters, the Fitchburg office also provides most of the quality assurance testing and technical support for products manufactured by other Promega facilities. In addition to research and development and manufacturing, the Fitchburg campus also is home to marketing, customer service, legal and human resources functions.

Share

Exclusive Research